0.03Open0.05Pre Close21 Volume39 Open Interest73.00Strike Price65.00Turnover66.89%IV6.59%PremiumNov 29, 2024Expiry Date0.00Intrinsic Value100Multiplier1DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0400Delta0.0282Gamma1562.00Leverage Ratio-0.0500Theta-0.0001Rho-62.47Eff Leverage0.0039Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
Great products sells itself, ask novo disk and how they sell ozempic
No comment yet